<DOC>
	<DOCNO>NCT02016547</DOCNO>
	<brief_summary>Intravenous ( IV ) Alteplase ( rt-PA ) gold standard brain infarction within 4 h 30 symptom onset . Efficacy therapy limit set large artery occlusion . For middle cerebral artery occlusion ( MCA ) internal carotid artery occlusion ( ICA ) , recanalization rate drop low 10 % . This element critical prognosis link recanalization . Arterial re-occlusions frequent may reach 30 % , limit IV thrombolysis efficacy.With endovascular approach , recanalization rate may reach 90 % last generation device . A recent meta-analysis show best candidate thrombectomy MCA occlusion . In coronary literature , endovascular therapy efficacy increase association antiplatelets abciximab . The aim study assess feasibility thrombectomy associate abciximab revascularisation ( TICI score ) , well safety ( symptomatic intracranial bleeding ) , order design clinical trial versus gold standard acute ischemic stroke revascularization strategy use IV rt-PA.This control , pilot study , evaluate feasibility safety thrombectomy abciximab versus IV rt-PA acute ischemic stroke patient within 4h30 symptom onset .</brief_summary>
	<brief_title>Thrombectomy Under Reopro Versus Alteplase Treat Stoke</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Infarction , Middle Cerebral Artery</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Abciximab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<mesh_term>Immunoglobulin Fab Fragments</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Clinical sign consistent acute ischemic stroke &lt; 4.5 hour Cerebral infarction middle cerebral artery occlusion , without hemorrhage document MRI CT 4 &lt; National Institute Health Stroke Score ( NIHSS ) &lt; 25 age &gt; 18 year prestroke functional dependance : modify Rankin score ≤ 2 subject subject 's legally authorize representative sign date Informed Consent Form accord french regulation ethic committee . pregnant lactate female coma ( vigilance NIHSS &gt; 1 ) epilepsy recent history stroke anticoagulant therapy International Normalized Ratio ( INR ) &gt; 1.7 ; heparin therapy within past 24 hour Temps de Cephaline Activee ( TCA ) extension previous subarachnoid hemorrhage clinical presentation suggest subarachnoid hemorrhage , even initial CT MRI scan normal know hereditary acquire hemorrhagics diathesis , coagulation factor deficiency uncontrolled hypertension define systolic blood pressure ≥ 185 millimeter mercury ( mmHg ) diastolic blood pressure &gt; 110 mmHg time admission time threat lumbar ar arterial puncture within past 7 day major surgery within past 2 month gastrointestinal hemorrhage urinary hemorrhage myocardial infarction within past 21 day pericarditis within past 3 month suspicion bacterial endocarditis within past 3 month previous aortic dissection baseline lab value : TCA &gt; 40 , platelet &lt; 100 000/mm3 , glucose &lt; 3 mmol/l &gt; 22 mmol/l hepatic insufficiency CT MRI evidence oh hemorrhage CT MRI evidence mass effect intracranial tumor CT show hypodensity MRI show hyperdensity involve great 1/3 middle cerebral artery territory ( ASPECT score &lt; 7 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Middle Cerebral Artery</keyword>
	<keyword>Thrombectomy</keyword>
	<keyword>Mechanical Thrombolysis</keyword>
	<keyword>Abciximab</keyword>
</DOC>